SCHEMBL3378592

SCHEMBL3378592

CCC/C=C\CCCCCC

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FAAH O00519 4/20 0.67
TRPV1 Q8NER1 1/20 0.67
TERT O14746 3/20 0.56
PTPN1 P18031 3/20 0.56
PPARG P37231 3/20 0.56
PPARD Q03181 3/20 0.56
PPARA Q07869 3/20 0.56
CYP1A2 P05177 2/20 0.56
MAPT P10636 2/20 0.56
CYP2C19 P33261 2/20 0.56
BLM P54132 2/20 0.56
HSD17B10 Q99714 2/20 0.56
FABP4 P15090 2/20 0.56
KMT2A Q03164 2/20 0.56
TOP1 P11387 2/20 0.56
GMNN O75496 1/20 0.56
USP2 O75604 1/20 0.56
LMNA P02545 1/20 0.56
POLB P06746 1/20 0.56
CYP2C9 P11712 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2837920 1.00 FAAH (0.67) FAAHTRPV1TERTPTPN1PPARG
SCHEMBL454819 1.00 FAAH (0.67) FAAHTRPV1TERTPTPN1PPARG
SCHEMBL454818 1.00 FAAH (0.67) FAAHTRPV1TERTPTPN1PPARG
SCHEMBL514736 1.00 FAAH (0.67) FAAHTRPV1TERTPTPN1PPARG
SCHEMBL5854348 1.00 FAAH (0.67) FAAHTRPV1TERTPTPN1PPARG
SCHEMBL5854970 1.00 FAAH (0.67) FAAHTRPV1TERTPTPN1PPARG
SCHEMBL2357077 1.00 FAAH (0.67) FAAHTRPV1TERTPTPN1PPARG
SCHEMBL5855889 1.00 FAAH (0.67) FAAHTRPV1TERTPTPN1PPARG
SCHEMBL5855886 1.00 FAAH (0.67) FAAHTRPV1TERTPTPN1PPARG
SCHEMBL20584432 1.00 FAAH (0.67) FAAHTRPV1TERTPTPN1PPARG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230183309-A1 STRUCTURALLY-STABILIZED GLUCAGON-LIKE PEPTIDE 1 PEPTIDES AND USES THEREOF DANA-FARBER CANCER INSTITUTE, INC. 2023-06-15 US disclosed
CN-108472973-A Printing watermark OMYA国际股份公司 2018-08-31 CN disclosed
CN-108473692-A The filler of surface treatment for ultra-thin breathable film OMYA国际股份公司 2018-08-31 CN disclosed
CN-108463593-A The method of marking substrates OMYA国际股份公司 2018-08-28 CN disclosed
WO-2010049678-A2 TREATMENT OF ENERGY UTILIZATION DISEASES SUMMIT CORPORATION PLC (GB) 2010-05-06 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230183309-A1 STRUCTURALLY-STABILIZED GLUCAGON-LIKE PEPTIDE 1 PEPTIDES AND USES THEREOF GLP1R, IAPP, GPR119 FAAH 1419/4885TRPV1 2498/4885TERT 3418/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.